A wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) has signed definitive agreements to invest USD 200 million for a 3% equity stake in Micro Life Sciences Private Limited (Meril), a leading Indian medical devices company. The deal values Meril at an enterprise value of USD 6.6 billion. The transaction is subject to approval from the Competition Commission of India (CCI). Following this investment, Meril will be backed by two prominent global investors—ADIA and Warburg Pincus.
Established by the Bilakhia Group, Meril is a global MedTech innovator dedicated to developing clinically advanced solutions across a wide range of specialties. These include Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics, and Surgical Robotics.
Headquartered in Vapi, India, Meril operates state-of-the-art, vertically integrated, and globally certified manufacturing and R&D facilities, across a 100 acre sustainable MedTech campus. The company employs more than 13,000 people, has 35+ global subsidiaries, and serves healthcare systems in 150+ countries. Meril is committed to becoming the world’s leading MedTech company, powered 100% by green energy, reinforcing its commitment to sustainable innovation.
With a robust in-house global R&D ecosystem and a portfolio of 200+ technology platforms, Meril continues to lead in global clinical research and education. Breakthrough innovations such as the Myval Transcatheter Heart Valve (THV) series, MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System highlight Meril’s dedication to next-generation innovation. Through its 12+ global training academies, Meril empowers over 10,000 healthcare professionals annually.
Sanjeev Bhatt, Senior Vice President – Strategy, Meril stated, ‘This investment by ADIA reinforces confidence in Meril’s long term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our R&D and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.’
About Meril
Meril is a global medical technology company headquartered in Vapi, India. With a strong emphasis on innovation, Meril develops clinically meaningful products aimed at enhancing patient outcomes across cardiovascular, orthopaedic, diagnostic, Endo Surgery and robotic surgery domains. Founded by the Bilakhia Group, the company is committed to sustainability, quality, and global impact.
